MEROLA, BARTOLOMEO
 Distribuzione geografica
Continente #
NA - Nord America 1.070
EU - Europa 625
AS - Asia 622
SA - Sud America 53
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.380
Nazione #
US - Stati Uniti d'America 1.056
SG - Singapore 282
CN - Cina 199
HK - Hong Kong 123
IT - Italia 120
DE - Germania 99
FI - Finlandia 83
NL - Olanda 79
RU - Federazione Russa 70
IE - Irlanda 61
SE - Svezia 53
BR - Brasile 45
UA - Ucraina 25
GB - Regno Unito 23
CA - Canada 12
CZ - Repubblica Ceca 9
CI - Costa d'Avorio 6
TR - Turchia 6
BD - Bangladesh 3
CL - Cile 3
EU - Europa 3
EC - Ecuador 2
IQ - Iraq 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
DZ - Algeria 1
FR - Francia 1
GE - Georgia 1
GY - Guiana 1
IN - India 1
IR - Iran 1
LT - Lituania 1
MY - Malesia 1
PE - Perù 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 2.380
Città #
Singapore 175
Chandler 163
Hong Kong 123
Millbury 111
Santa Clara 99
Jacksonville 91
Princeton 73
Amsterdam 71
Nanjing 70
Naples 43
Wilmington 41
Norwalk 33
Beijing 27
Nanchang 26
Ashburn 19
Shenyang 11
Boston 10
Kunming 10
Ottawa 10
Brno 9
Helsinki 9
Jiaxing 8
Indiana 7
Tianjin 7
Hebei 6
Napoli 6
Houston 5
Moscow 5
Munich 5
Torino 5
Belo Horizonte 4
Changsha 4
Lanzhou 4
Ningbo 4
Rio de Janeiro 4
Casoria 3
Dallas 3
Guangzhou 3
San Diego 3
São Paulo 3
Ankara 2
Baghdad 2
Brasília 2
Cambridge 2
Changchun 2
Dhaka 2
Falls Church 2
Jinan 2
New York 2
Nocera Superiore 2
Quito 2
San Francisco 2
Seattle 2
Shanghai 2
Toronto 2
Valle 2
Woodbridge 2
Yellow Springs 2
Zhengzhou 2
Alessandria 1
Algiers 1
Angra dos Reis 1
Ann Arbor 1
Araras 1
Ardabil 1
Arequipa 1
Bronx 1
Camaragibe 1
Cametá 1
Chatsworth 1
Ciudad Obregón 1
Curvelo 1
Dearborn 1
Diamantina 1
Dubai 1
Dublin 1
Erzurum 1
Fairfield 1
Falkenstein 1
Formia 1
Georgetown 1
Governador Valadares 1
Grammichele 1
Gravataí 1
Hangzhou 1
Huaihua 1
Ibotirama 1
Ipatinga 1
Istanbul 1
Itapemirim 1
Itaquaquecetuba 1
Jinhua 1
João Neiva 1
Kuala Lumpur 1
Lafayette 1
London 1
Los Angeles 1
Manaus 1
Marcianise 1
Maringá 1
Totale 1.392
Nome #
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 64
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 56
Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD) 50
Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. 49
Cardiac effects of GH 49
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas 49
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 47
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 47
Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain 45
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 45
Acromegaly 44
Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood 43
Changes of lung volumes and respiratory muscle strength in patients with growth hormone deficiency 43
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 43
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 42
CV 205-502 treatment in therapy-resistant acromegalic patients 40
Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas 40
Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD 39
Effect of different dopaminergic agents in the treatment of acromegaly 39
The use of intercavernous sinuses phlebography in the diagnosis of ACTH-secreting microadenomas 38
Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography 37
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 37
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. 36
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 36
Acute administration of hexarelin stimulates GH secretion during day and night in normal men. 36
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 36
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 36
Abnormal vascular reactivity in growth hormone deficiency. 35
Effect of growth hormone on cardiac function 35
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly 35
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 34
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 33
Hyperthyroidism due to a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma associated with functional hyperprolactinaemia. A case report. 33
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 32
Effect of a short-term treatment with recombinant growth hormone (GH) on adrenal responsiveness to corticotrophin stimulation in children affected by isolated GH deficiency 32
Hormonal gradients between inferior petrosal sinuses in various pituitary diseases 32
Prediction of efficacy of octreotide therapy in patients with acromegaly 32
Bilateral and simultaneous inferior petrosal sinus sampling in the early diagnosis of an ACTH-producing pituitary microadenoma and its detection by magnetic resonance one year later 32
Comparison of anterior pituitary hormone levels between the inferior petrosal sinuses and peripheral blood in various pituitary disorders during perihypophyseal phlebography 31
Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas 30
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 30
Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration 30
Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases 30
Efficacia e tollerabilità dell' octreotide (sandostatin, Sandoz) nell' acromegalia: vaòutazione su 20 pazienti. 30
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 29
Effect of octreotide pretreatment on surgical outcome in acromegaly 29
Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. 29
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 28
New medical approaches in pituitary adenomas. 27
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 27
Failure of long-term therapy with sodium valproate in Cushing's disease. 26
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 26
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. 26
Fixity of vocal cords and laryngocele in acromegaly 25
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas 25
Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis 25
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 25
Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration 25
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia 25
Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies 25
Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly. 24
Prolactin in the inferior petrosal sinuses 24
Height, weight, height velocity of primary school population sample in Campania region 24
Rapid and long-lasting suppression on prolactin secretion and shrinkage of prolactinomas with improved tolerability after injection of long-acting repeatable form of bromocriptine (Parlodel LAR) 24
Changes in GH-releasing hormone (GHRH) and somatostatin (SRIF) levels in hypophyseal portal blood (HPB) of conscious sheep during acute emotional stress. 24
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. 23
Bone mineral density and circulating cytokines in patients with acromegaly 23
Langerhans cell histiocytosis, diabetes insipidus, hyperprolactinemia and empty sella: a four-fold association. Report of two cases 23
Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. 22
The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency 22
Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly 21
Prostatic hyperplasia: an unknown feature of acromegaly 21
Impaired cardiac performance is a distinct feature of uncomplicated acromegaly 20
Growth hormone and the heart 19
Totale 2.448
Categoria #
all - tutte 13.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 0 0 0 0 3 12 25 69
2020/2021104 0 5 6 6 5 46 5 1 7 6 10 7
2021/2022452 0 0 0 0 10 59 7 11 68 44 73 180
2022/2023438 73 30 18 17 56 35 4 37 55 72 25 16
2023/2024258 17 52 44 22 7 8 6 6 0 5 41 50
2024/2025670 84 118 5 11 31 110 214 97 0 0 0 0
Totale 2.448